Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Fisher

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer of the Year: "Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Timing of potassium monitoring in females treated for acne with spironolactone is not optimal: A retrospective cohort study"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Retrospective cohort study characterizing PD-1/PD-L1 checkpoint inhibition associated Stevens-Johnson syndrome and toxic epidermal necrolysis"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Reticulated livedoid skin patterns after soft-tissue filler-related vascular adverse events"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A randomized controlled trial in a real-world setting"Craig Fisher, Wendi E Wohltmann
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer of the Year: "Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Timing of potassium monitoring in females treated for acne with spironolactone is not optimal: A retrospective cohort study"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Retrospective cohort study characterizing PD-1/PD-L1 checkpoint inhibition associated Stevens-Johnson syndrome and toxic epidermal necrolysis"Craig Fisher, Eden Lake
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changers: "Reticulated livedoid skin patterns after soft-tissue filler-related vascular adverse events"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery"Craig Fisher, Wendi E Wohltmann
Journal of the American Academy of Dermatology|October 31, 2025
JAAD Game Changer: "Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A randomized controlled trial in a real-world setting"Craig Fisher, Wendi E Wohltmann
Pageof 2